logo

Aurinia Pharmaceuticals Inc. (AUPH)



Trade AUPH now with
  Date
  Headline
12/17/2020 4:03:54 AM Aurinia Announces Collaboration Deal With Otsuka Pharma For Development Of Voclosporin In Europe And Japan
9/28/2020 6:09:40 AM Aurinia Completes Final Patient Treatment In AUDREY Phase 2/3 Clinical Trial Of Voclosporin Ophthalmic Solution
7/27/2020 10:34:12 AM Aurinia Closes $200 Mln Public Offering Of Common Shares
7/22/2020 11:11:24 PM Aurinia Pharma Announces Pricing Of Underwritten Public offering Of 13.33 Mln Shares At US$15.00/shr
6/22/2020 6:09:21 AM Aurinia Completes Patient Enrollment Into AUDREY Phase 2/3 Clinical Trial Of Voclosporin Ophthalmic Solution
6/9/2020 6:10:21 AM Aurinia Pharma Presents Addl AURORA Pivotal Trial Safety Data At ERA-EDTA Virtual Congress 2020
6/5/2020 7:11:24 AM AbbVie, Harbour BioMed, Utrecht University And Erasmus Medical Center Announcee Collaboation
6/5/2020 7:09:05 AM Aurinia Presents New Subgroup Analyses From Completed AURORA Pivotal Trial Of Voclosporin
6/3/2020 6:08:48 AM Aurinia Pharma Says Nine Incumbent Directors Elected At Annual General Meeting
5/26/2020 6:08:41 AM Aurinia Completes Submission Of NDA To FDA For Voclosporin For Treatment Of Lupus Nephritis
5/14/2020 4:04:02 PM Aurinia Q1 Loss/share $0.15 Vs. Loss $0.14 Year Ago
4/27/2020 6:08:38 AM Aurinia Appoints Joe Miller As CFO
4/20/2020 6:11:31 AM Aurinia Appoints Timothy Walbert To Board